Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | MIRMMirum Pharmaceuticals, Inc.FY2025 · Dec |
|---|---|
| Revenue | $521.31M |
| Revenue, yoy | +54.7% |
| Net income | $23.36M |
| Net income, yoy | +73.4% |
| Net margin | -4.5% |
| Free cash flow | $54.87M |
| FCF margin | 10.5% |
| EPS, diluted | $0.47 |
Add another company.